TTM
24.6%
YoY change
−2.21pp
Trough year (2002)
-1.3%
Peak year (2012)
36.3%
Latest annual
26.7%
FCF Margin history chart for Bristol-Myers Squibb (BMY) from 1989 to 2025
Latest: 26.7%
FCF Margin change chart for Bristol-Myers Squibb (BMY) from 1989 to 2025
Latest: −2.21pp
FCF Margin history table for Bristol-Myers Squibb (BMY) from 1989 to 2025
| 2025 | 26.7% | -2.21pp | ||
| 2024 | 28.9% | +0.76pp | ||
| 2023 | 28.1% | +2.23pp | ||
| 2022 | 25.9% | -6.96pp | ||
| 2021 | 32.8% | +1.56pp | ||
| 2020 | 31.3% | +3.07pp | ||
| 2019 | 28.2% | +1.10pp | ||
| 2018 | 27.1% | +6.79pp | ||
| 2017 | 20.3% | +10.83pp | ||
| 2016 | 9.5% | +1.73pp | ||
| 2015 | 7.8% | -8.75pp | ||
| 2014 | 16.5% | -1.85pp | ||
| 2013 | 18.4% | -17.92pp | ||
| 2012 | 36.3% | +15.23pp | ||
| 2011 | 21.1% | +0.18pp | ||
| 2010 | 20.9% | +3.14pp | ||
| 2009 | 17.7% | +4.30pp | ||
| 2008 | 13.4% | +1.49pp | ||
| 2007 | 11.9% | +4.74pp | ||
| 2006 | 7.2% | +1.64pp | ||
| 2005 | 5.6% | -6.65pp | ||
| 2004 | 12.2% | +0.14pp | ||
| 2003 | 12.1% | +13.38pp | ||
| 2002 | -1.3% | -23.85pp | ||
| 2001 | 22.5% | +0.24pp | ||
| 2000 | 22.3% | +4.92pp | ||
| 1999 | 17.4% | +1.01pp | ||
| 1998 | 16.4% | +6.14pp | ||
| 1997 | 10.2% | -3.31pp | ||
| 1996 | 13.5% | -0.88pp | ||
| 1995 | 14.4% | +0.01pp | ||
| 1994 | 14.4% | -3.19pp | ||
| 1993 | 17.6% | +5.23pp | ||
| 1992 | 12.4% | +1.56pp | ||
| 1991 | 10.8% | -1.21pp | ||
| 1990 | 12.0% | +5.12pp | ||
| 1989 | 6.9% | — |
- 202526.7%-2.21pp
- 202428.9%+0.76pp
- 202328.1%+2.23pp
- 202225.9%-6.96pp
- 202132.8%+1.56pp
- 202031.3%+3.07pp
- 201928.2%+1.10pp
- 201827.1%+6.79pp
- 201720.3%+10.83pp
- 20169.5%+1.73pp
- 20157.8%-8.75pp
- 201416.5%-1.85pp
- 201318.4%-17.92pp
- 201236.3%+15.23pp
- 201121.1%+0.18pp
- 201020.9%+3.14pp
- 200917.7%+4.30pp
- 200813.4%+1.49pp
- 200711.9%+4.74pp
- 20067.2%+1.64pp
- 20055.6%-6.65pp
- 200412.2%+0.14pp
- 200312.1%+13.38pp
- 2002-1.3%-23.85pp
- 200122.5%+0.24pp
- 200022.3%+4.92pp
- 199917.4%+1.01pp
- 199816.4%+6.14pp
- 199710.2%-3.31pp
- 199613.5%-0.88pp
- 199514.4%+0.01pp
- 199414.4%-3.19pp
- 199317.6%+5.23pp
- 199212.4%+1.56pp
- 199110.8%-1.21pp
- 199012.0%+5.12pp
- 19896.9%—
FCF Margin values are taken from Bristol-Myers Squibb's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About FCF Margin at Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's latest reported free cash flow margin is 24.6%. Free cash flow margin is free cash flow divided by revenue — the share of each sales dollar that converts into cash after capital expenditures. Because free cash flow cannot be inflated by non-cash accounting, FCF margin is a clean read on how efficiently a business turns revenue into deployable cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
2025's annual free cash flow margin for Bristol-Myers Squibb (BMY) came in at 26.65% – contracted 2.2 percentage points year-over-year.
The record annual free cash flow margin stands at 36.28%, reached in 2012; the historical low of -1.31% was recorded in 2002.
Bristol-Myers Squibb FCF Margin by Year
Bristol-Myers Squibb FCF Margin 2025: 26.7%
In 2025, Bristol-Myers Squibb reported free cash flow margin of 26.65%, contracted 2.2 percentage points from 2024.
Bristol-Myers Squibb FCF Margin 2024: 28.9%
Bristol-Myers Squibb free cash flow margin in 2024 was 28.87%, expanded 0.8 percentage points from 2023.
Bristol-Myers Squibb FCF Margin 2023: 28.1%
2023's free cash flow margin for Bristol-Myers Squibb came in at 28.11%, expanded 2.2 percentage points from 2022.
Bristol-Myers Squibb FCF Margin 2022: 25.9%
Bristol-Myers Squibb posted free cash flow margin of 25.88% in 2022, contracted 7.0 percentage points from 2021.
Bristol-Myers Squibb FCF Margin 2021: 32.8%
Bristol-Myers Squibb free cash flow margin in 2021 was 32.84%.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers by FCF Margin
Healthcare peers of Bristol-Myers Squibb (BMY), ranked by their latest free cash flow margin
| 33.2% | |
| 23.1% | |
| 21.5% | |
| 18.8% | |
| 18.4% | |
| 15.1% | |
| 9.4% | |
| 4.4% |
- 33.2%
- 23.1%
- 21.5%
- 18.8%
- 15.1%
Frequently asked questions
Bristol-Myers Squibb (BMY) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation